The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic
OBJECTIVES: To describe the MORPHEOS (Morbidity in patients with uncontrolled HTN and OSA) trial, and describe the challenges imposed by the COVID-19 pandemic. METHODS: MORPHEOS is a multicenter (n=6) randomized controlled trial designed to evaluate the blood pressure (BP) lowering effects of treatment with continuous positive airway pressure (CPAP) or placebo (nasal strips) for 6 months in adult patients with uncontrolled hypertension (HTN) and moderate-to-severe obstructive sleep apnea (OSA). Patients using at least one antihypertensive medication were included. Uncontrolled HTN was confirmed by at least one abnormal parameter in the 24-hour ABPM and ≥80% medication adherence evaluated by pill counting after the run-in period. OSA was defined by an apnea-hypopnea index ≥15 events/hours. The co-primary endpoints are brachial BP (office and ambulatory BP monitoring, ABPM) and central BP. Secondary outcomes include hypertension-mediated organ damage (HMOD) to heart, aorta, eye, and kidney. We pre-specified several sub-studies from this investigation. Visits occur once a week in the first month and once a month thereafter. The programmed sample size was 176 patients but the pandemic prevented this final target. A post-hoc power analysis will be calculated from the final sample. ClinicalTrials.gov: NCT02270658. RESULTS: The first 100 patients are predominantly males (n=69), age: 52±10 years, body mass index: 32.7±3.9 kg/m2 with frequent co-morbidities. CONCLUSIONS: The MORPHEOS trial has a unique study design including a run-in period; pill counting, and detailed analysis of hypertension-mediated organ damage in patients with uncontrolled HTN that will allow clarification of the impact of OSA treatment with CPAP.
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Faculdade de Medicina / USP
2021
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100307 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1807-59322021000100307 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1807-593220210001003072021-09-01The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemicCruz,Fernanda C.S.G.Drager,Luciano F.Queiróz,Daniel B.C.Souza,Gabriela A.Pedrosa,Rodrigo P.Patriota,Tarcya L.G CoutoDórea,Egidio L.Vieira,Marcelo Luiz C.Righi,Camila G.Martinez,DenisSilva,Geruza A. daSilva,Giovanio V.Pio-Abreu,AndreaLotufo,Paulo A.Benseãor,Isabela M.Bortolotto,Luiz A.Fuchs,Flávio D.Lorenzi-Filho,Geraldo Obstructive Sleep Apnea Hypertension CPAP OBJECTIVES: To describe the MORPHEOS (Morbidity in patients with uncontrolled HTN and OSA) trial, and describe the challenges imposed by the COVID-19 pandemic. METHODS: MORPHEOS is a multicenter (n=6) randomized controlled trial designed to evaluate the blood pressure (BP) lowering effects of treatment with continuous positive airway pressure (CPAP) or placebo (nasal strips) for 6 months in adult patients with uncontrolled hypertension (HTN) and moderate-to-severe obstructive sleep apnea (OSA). Patients using at least one antihypertensive medication were included. Uncontrolled HTN was confirmed by at least one abnormal parameter in the 24-hour ABPM and ≥80% medication adherence evaluated by pill counting after the run-in period. OSA was defined by an apnea-hypopnea index ≥15 events/hours. The co-primary endpoints are brachial BP (office and ambulatory BP monitoring, ABPM) and central BP. Secondary outcomes include hypertension-mediated organ damage (HMOD) to heart, aorta, eye, and kidney. We pre-specified several sub-studies from this investigation. Visits occur once a week in the first month and once a month thereafter. The programmed sample size was 176 patients but the pandemic prevented this final target. A post-hoc power analysis will be calculated from the final sample. ClinicalTrials.gov: NCT02270658. RESULTS: The first 100 patients are predominantly males (n=69), age: 52±10 years, body mass index: 32.7±3.9 kg/m2 with frequent co-morbidities. CONCLUSIONS: The MORPHEOS trial has a unique study design including a run-in period; pill counting, and detailed analysis of hypertension-mediated organ damage in patients with uncontrolled HTN that will allow clarification of the impact of OSA treatment with CPAP.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.76 20212021-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100307en10.6061/clinics/2021/e2926 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Cruz,Fernanda C.S.G. Drager,Luciano F. Queiróz,Daniel B.C. Souza,Gabriela A. Pedrosa,Rodrigo P. Patriota,Tarcya L.G Couto Dórea,Egidio L. Vieira,Marcelo Luiz C. Righi,Camila G. Martinez,Denis Silva,Geruza A. da Silva,Giovanio V. Pio-Abreu,Andrea Lotufo,Paulo A. Benseãor,Isabela M. Bortolotto,Luiz A. Fuchs,Flávio D. Lorenzi-Filho,Geraldo |
spellingShingle |
Cruz,Fernanda C.S.G. Drager,Luciano F. Queiróz,Daniel B.C. Souza,Gabriela A. Pedrosa,Rodrigo P. Patriota,Tarcya L.G Couto Dórea,Egidio L. Vieira,Marcelo Luiz C. Righi,Camila G. Martinez,Denis Silva,Geruza A. da Silva,Giovanio V. Pio-Abreu,Andrea Lotufo,Paulo A. Benseãor,Isabela M. Bortolotto,Luiz A. Fuchs,Flávio D. Lorenzi-Filho,Geraldo The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic |
author_facet |
Cruz,Fernanda C.S.G. Drager,Luciano F. Queiróz,Daniel B.C. Souza,Gabriela A. Pedrosa,Rodrigo P. Patriota,Tarcya L.G Couto Dórea,Egidio L. Vieira,Marcelo Luiz C. Righi,Camila G. Martinez,Denis Silva,Geruza A. da Silva,Giovanio V. Pio-Abreu,Andrea Lotufo,Paulo A. Benseãor,Isabela M. Bortolotto,Luiz A. Fuchs,Flávio D. Lorenzi-Filho,Geraldo |
author_sort |
Cruz,Fernanda C.S.G. |
title |
The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic |
title_short |
The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic |
title_full |
The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic |
title_fullStr |
The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic |
title_full_unstemmed |
The effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - Study design and challenges during the COVID-19 pandemic |
title_sort |
effect of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea and uncontrolled hypertension - study design and challenges during the covid-19 pandemic |
description |
OBJECTIVES: To describe the MORPHEOS (Morbidity in patients with uncontrolled HTN and OSA) trial, and describe the challenges imposed by the COVID-19 pandemic. METHODS: MORPHEOS is a multicenter (n=6) randomized controlled trial designed to evaluate the blood pressure (BP) lowering effects of treatment with continuous positive airway pressure (CPAP) or placebo (nasal strips) for 6 months in adult patients with uncontrolled hypertension (HTN) and moderate-to-severe obstructive sleep apnea (OSA). Patients using at least one antihypertensive medication were included. Uncontrolled HTN was confirmed by at least one abnormal parameter in the 24-hour ABPM and ≥80% medication adherence evaluated by pill counting after the run-in period. OSA was defined by an apnea-hypopnea index ≥15 events/hours. The co-primary endpoints are brachial BP (office and ambulatory BP monitoring, ABPM) and central BP. Secondary outcomes include hypertension-mediated organ damage (HMOD) to heart, aorta, eye, and kidney. We pre-specified several sub-studies from this investigation. Visits occur once a week in the first month and once a month thereafter. The programmed sample size was 176 patients but the pandemic prevented this final target. A post-hoc power analysis will be calculated from the final sample. ClinicalTrials.gov: NCT02270658. RESULTS: The first 100 patients are predominantly males (n=69), age: 52±10 years, body mass index: 32.7±3.9 kg/m2 with frequent co-morbidities. CONCLUSIONS: The MORPHEOS trial has a unique study design including a run-in period; pill counting, and detailed analysis of hypertension-mediated organ damage in patients with uncontrolled HTN that will allow clarification of the impact of OSA treatment with CPAP. |
publisher |
Faculdade de Medicina / USP |
publishDate |
2021 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100307 |
work_keys_str_mv |
AT cruzfernandacsg theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT dragerlucianof theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT queirozdanielbc theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT souzagabrielaa theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT pedrosarodrigop theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT patriotatarcyalgcouto theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT doreaegidiol theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT vieiramarceloluizc theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT righicamilag theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT martinezdenis theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT silvageruzaada theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT silvagiovaniov theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT pioabreuandrea theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT lotufopauloa theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT benseaorisabelam theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT bortolottoluiza theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT fuchsflaviod theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT lorenzifilhogeraldo theeffectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT cruzfernandacsg effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT dragerlucianof effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT queirozdanielbc effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT souzagabrielaa effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT pedrosarodrigop effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT patriotatarcyalgcouto effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT doreaegidiol effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT vieiramarceloluizc effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT righicamilag effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT martinezdenis effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT silvageruzaada effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT silvagiovaniov effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT pioabreuandrea effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT lotufopauloa effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT benseaorisabelam effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT bortolottoluiza effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT fuchsflaviod effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic AT lorenzifilhogeraldo effectofcontinuouspositiveairwaypressureonbloodpressureinpatientswithobstructivesleepapneaanduncontrolledhypertensionstudydesignandchallengesduringthecovid19pandemic |
_version_ |
1756432390716129280 |